PharmiWeb.com - Global Pharma News & Resources
17-Jun-2020

ADVFN Reveals Most Tracked Stocks During Lockdown

- Genedrive, Omega Diagnostics, FRP Advisory see greatest spike in investor traffic

 

 

Biotech, pharmaceutical and health care equipment and services are amongst the sectors seeing the highest surge of private investor interest since March 23rd.  

 

Using its Follow Feed tool, stocks, shares and crypto website ADVFN (www.advfn.com) can reveal that diagnostics firm Genedrive plc, which has developed two coronavirus tests, has seen a 1400% increase in ‘follows’ since lockdown began.

 

Omega Diagnostics Group plc, which recently shipped its first Covid-19 testing kits, has seen a 455% rise in follows and FRP Advisory Group plc, a leading UK professional services firm specialising in restructuring advisory, has registered a 388% increase. Avacta Group plc, which raised £48m on June 4th to support the development of its new Covid-19 test, has experienced a 375% upsurge; biotech company Tiziana Life Sciences plc completes the top five with a 348% increase.

 

 

Top 10 UK stocks that have seen the greatest spike in investor interest [1]:   

 

Company

Ticker

Increase

Genedrive

LSE:GDR

1400%

Omega Diagnostics Group 

LSE:ODX

455%

FRP Advisory

 

LSE:FRP

388%

Avacta Group 

LSE:AVCT

375%

Tiziana Life Sciences

 

LSE:TILS

348%

4D Pharma

LSE:DDDD

341%

Synairgen

LSE:SNG

327%

Sig

LSE:SHI

177%

Aston Martin Lagonda

LSE:AML

165%

Tekcapital

 

LSE:TEK

127%

 

 

Lloyds is currently the most monitored UK stock by investors on ADVFN followed by Barclays, Vodafone, Hurricane Energy and BP. However, these stocks have seen a relatively modest 6%-16% increase in interest during the lockdown period.

 

ADVFN’s Follow Feed tool provides essential market insights to private investors by keeping track of the stocks and cryptos that they select (‘follow’). It alerts them to key events such as price breakouts, unusual price action, high volume trades, order book activity, news and announcements and forum comments as they are happening in a rolling ‘Follow Feed’ timeline.

 

“Biotech stocks are red hot in London and the US,” said Clem Chambers, CEO of ADVFN. “Follow Feed is the go-to tool on ADVFN for users that want to keep up to date, blow-by-blow with developments in their conviction holdings.”

About ADVFN  

ADVFN (www.advfn.com) is an award-winning global stocks, shares and crypto information website providing market-leading financial tools and data to private investors around the world.

 

Offering real-time share prices, news feeds, charting, portfolio management, monitor lists, financials (fundamentals), data from global stock exchanges, Level 2 and the most active financial bulletin board in the UK (along with many other features), the site is the destination of choice for day traders and retail investors.

Established in the last quarter of 1999, ADVFN (LSE:AFN) was floated on the London Stock Exchange’s AIM market in March 2000. The site currently has approximately 36 million users worldwide and a billion page impressions a year.

Originally a UK-based site, the company currently operates in the US, UK, Brazil, Japan and Dubai.

ADVFN has a joint venture in Brazil, a country in which ADVFN has a geographic and language targeted website. This is in addition to its US, French, German, Italian, Canadian, Japanese, Indian, Mexican and Filipino ADVFN financial sites.

In September 2006 ADVFN acquired InvestorsHub.com, a leading online investment community website in the North American market.

ADVFN bought AllIPO, an online IPO trading platform, as well as stock brokerages TSCTrade and Throgmorton Street Capital in July 2009.

In 2013 ADVFN acquired Finance Manila, a key resource in a rapidly growing market economy.


[1] Data is taken from March 23rd to June 9th, 2020

Editor Details

  • Company:
    • ADVFN
  • Name:
    • ADVFN
Last Updated: 17-Jun-2020